{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T15:07:55Z","timestamp":1778771275585,"version":"3.51.4"},"reference-count":21,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2017,2,13]],"date-time":"2017-02-13T00:00:00Z","timestamp":1486944000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Blood Cells, Molecules, and Diseases"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1016\/j.bcmd.2017.01.013","type":"journal-article","created":{"date-parts":[[2017,1,27]],"date-time":"2017-01-27T02:48:01Z","timestamp":1485485281000},"page":"232-238","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["Design of a framework for the deployment of collaborative independent rare disease-centric registries: Gaucher disease registry model"],"prefix":"10.1016","volume":"68","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6303-9469","authenticated-orcid":false,"given":"Matthew I.","family":"Bellgard","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathryn R.","family":"Napier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alan H.","family":"Bittles","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffrey","family":"Szer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sue","family":"Fletcher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nikolajs","family":"Zeps","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adam A.","family":"Hunter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jack","family":"Goldblatt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcmd.2017.01.013_bb0005","doi-asserted-by":"crossref","first-page":"290","DOI":"10.4103\/0975-7406.72128","article-title":"Orphan drug: development trends and strategies","volume":"2","author":"Sharma","year":"2010","journal-title":"J. Pharm. Bioallied Sci."},{"key":"10.1016\/j.bcmd.2017.01.013_bb0010","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1016\/S0140-6736(15)00827-2","article-title":"Post-authorisation assessment of orphan drugs","volume":"386","author":"Hollak","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.bcmd.2017.01.013_bb0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1750-1172-7-50","article-title":"Key outcomes from stakeholder workshops at a symposium to inform the development of an Australian national plan for rare diseases","volume":"7","author":"Molster","year":"2012","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.bcmd.2017.01.013_bb0020","doi-asserted-by":"crossref","first-page":"2835","DOI":"10.1001\/archinte.160.18.2835","article-title":"The Gaucher registry: demographics and disease characteristics of 1698 patients with Gaucher disease","volume":"160","author":"Charrow","year":"2000","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.bcmd.2017.01.013_bb0025","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1002\/ajh.24054","article-title":"The history and accomplishments of the ICGG Gaucher registry","volume":"90","author":"Weinreb","year":"2015","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.bcmd.2017.01.013_bb0030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1750-1172-7-77","article-title":"The French Gaucher's disease registry: clinical characteristics, complications and treatment of 562 patients","volume":"7","author":"Stirnemann","year":"2012","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.bcmd.2017.01.013_bb0035","first-page":"792","article-title":"Report of the Spanish Gaucher's disease registry: clinical and genetic characteristics","volume":"85","author":"Giraldo","year":"2000","journal-title":"Haematologica"},{"key":"10.1016\/j.bcmd.2017.01.013_bb0040","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1750-1172-7-17","article-title":"Mapping the genetic and clinical characteristics of Gaucher disease in the Iberian Peninsula","volume":"7","author":"Giraldo","year":"2012","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.bcmd.2017.01.013_bb0045","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.ymgme.2006.08.009","article-title":"Phenotypic and genotypic heterogeneity in Gaucher disease type 1: a comparison between Brazil and the rest-of-the-world","volume":"90","author":"Sobreira","year":"2007","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.bcmd.2017.01.013_bb0050","series-title":"3238.0.55.001\u2014Estimates of Aboriginal and Torres Strait Islander Australians, June 2011","author":"Australian Bureau of Statistics (ABS)","year":"2013"},{"key":"10.1016\/j.bcmd.2017.01.013_bb0055","series-title":"3412.0\u2014Migration, Australia, 2014\u201315","author":"Australian Bureau of Statistics (ABS)","year":"2016"},{"key":"10.1016\/j.bcmd.2017.01.013_bb0060","doi-asserted-by":"crossref","first-page":"E2356","DOI":"10.1002\/humu.22154","article-title":"A modular approach to disease registry design: successful adoption of an internet-based rare disease registry","volume":"33","author":"Bellgard","year":"2012","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.bcmd.2017.01.013_bb0065","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/1751-0473-8-21","article-title":"Dispelling myths about rare disease registry system development","volume":"8","author":"Bellgard","year":"2013","journal-title":"Source Code Biol. Med."},{"key":"10.1016\/j.bcmd.2017.01.013_bb0070","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1751-0473-9-14","article-title":"Second generation registry framework","volume":"9","author":"Bellgard","year":"2014","journal-title":"Source Code Biol. Med."},{"key":"10.1016\/j.bcmd.2017.01.013_bb0075","first-page":"8","article-title":"A registry framework enabling patient-centred care","volume":"214","author":"Bellgard","year":"2015","journal-title":"Stud. Health Technol. Inform."},{"key":"10.1016\/j.bcmd.2017.01.013_bb0080","doi-asserted-by":"crossref","unstructured":"Napier KR, Pang J, Lamont L, Walker CE, Dawkins HJS, Hunter AA, van Bockxmeer FM, Watts GF, Bellgard MI. A web-based registry for familial hypercholesterolaemia. Heart, Lung and Circulation, http:\/\/dx.doi.org\/10.1016\/j.hlc.2016.10.019 (In press).","DOI":"10.1016\/j.hlc.2016.10.019"},{"key":"10.1016\/j.bcmd.2017.01.013_bb0085","doi-asserted-by":"crossref","first-page":"447","DOI":"10.3414\/ME14-02-0026","article-title":"A comprehensive assessment tool for patient registry software systems: the CIPROS checklist","volume":"54","author":"Lindoerfer","year":"2015","journal-title":"Methods Inf. Med."},{"key":"10.1016\/j.bcmd.2017.01.013_bb0090","series-title":"Joint Declaration 10 Key Principles of Rare Disease Patient Registries","author":"EURORDIS-NORD-CORD","year":"2012"},{"key":"10.1016\/j.bcmd.2017.01.013_bb0095","author":"EUCERD"},{"key":"10.1016\/j.bcmd.2017.01.013_bb0105","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1177\/1740774512438980","article-title":"National Institute of Neurological Disorders and Stroke Common Data Element Project\u2014approach and methods","volume":"9","author":"Grinnon","year":"2012","journal-title":"Clin. Trials"},{"key":"10.1016\/j.bcmd.2017.01.013_bb0110","author":"The Django open source project"}],"container-title":["Blood Cells, Molecules, and Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1079979616301668?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1079979616301668?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T12:33:21Z","timestamp":1761050001000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1079979616301668"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2]]},"references-count":21,"alternative-id":["S1079979616301668"],"URL":"https:\/\/doi.org\/10.1016\/j.bcmd.2017.01.013","relation":{},"ISSN":["1079-9796"],"issn-type":[{"value":"1079-9796","type":"print"}],"subject":[],"published":{"date-parts":[[2018,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Design of a framework for the deployment of collaborative independent rare disease-centric registries: Gaucher disease registry model","name":"articletitle","label":"Article Title"},{"value":"Blood Cells, Molecules, and Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcmd.2017.01.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}